Tiprelestat for treatment of hospitalized COVID-19: results of the double-blind randomized placebo-controlled COMCOVID trial

Authors

Johannes-Josef Tebbe
Stephan Budweiser (ORCID: https://orcid.org/0000-0003-2456-8410)
Ingmar Bergs (ORCID: https://orcid.org/0000-0002-8452-0964)
Stephan Walterspacher (ORCID: https://orcid.org/0000-0003-3061-1251)
Hans‐Heinrich Henneicke‐von Zepelin (ORCID: https://orcid.org/0000-0001-5473-5887)
Michael Dreher (ORCID: https://orcid.org/0000-0002-3452-5329)
Stephan Sorichter
Tom Bollmann (ORCID: https://orcid.org/0000-0002-0157-7691)
Henning Wege (ORCID: https://orcid.org/0000-0002-5924-796X)
Oliver Wiedow
Stefan Lüth (ORCID: https://orcid.org/0000-0001-9946-0960)
Hagen Kelm

Institutions

Witten/Herdecke University (DE)
Bielefeld University (DE)
Hochschule Bielefeld (DE)
Klinikum Esslingen (DE)
Universitätsklinikum Aachen (DE)
RoMed Kliniken (DE)
Klinikum Bielefeld (DE)
Neovii Biotech (Germany) (DE)
Medizinische Hochschule Brandenburg Theodor Fontane (DE)
St. Josefskrankenhaus Freiburg (DE)
University of Applied Sciences Stralsund (DE)
Universitätsklinikum Brandenburg an der Havel (DE)
RWTH Aachen University (DE)

Publication Details

Journal: Advances in Therapy
Published: 2025-09-16
DOI: https://doi.org/10.1007/s12325-025-03362-w
Primary Topic: COVID-19 Clinical Research Studies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Tiprelestat for treatment of hospitalized COVID-19: results of the double-blind randomized placebo-controlled COMCOVID trial

Johannes-Josef Tebbe, Stephan Budweiser, Ingmar Bergs, Stephan Walterspacher et al.

Sep 16, 2025

Advances in Therapy

COVID-19 Clinical Research Studies

article

Tiprelestat for treatment of hospitalized COVID-19: results of the double-blind randomized placebo-controlled COMCOVID trial

Johannes-Josef Tebbe, Stephan Budweiser, Ingmar Bergs, Stephan Walterspacher, Hans‐Heinrich Henneicke‐von Zepelin, Michael Dreher, Stephan Sorichter, Tom Bollmann, Henning Wege, Oliver Wiedow, Stefan Lüth, Hagen Kelm

September 16, 2025article en

Abstract

No abstract available for this paper.

Advances in TherapyVol. 42(11)

Witten/Herdecke University (DE), Bielefeld University (DE), Hochschule Bielefeld (DE), Klinikum Esslingen (DE), Universitätsklinikum Aachen (DE), RoMed Kliniken (DE), Klinikum Bielefeld (DE), Neovii Biotech (Germany) (DE), Medizinische Hochschule Brandenburg Theodor Fontane (DE), St. Josefskrankenhaus Freiburg (DE), University of Applied Sciences Stralsund (DE), Universitätsklinikum Brandenburg an der Havel (DE), RWTH Aachen University (DE)

Openalex Percentile: Top 70%

COVID-19 Clinical Research Studies

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Tiprelestat for treatment of hospitalized COVID-19: results of the double-blind randomized placebo-controlled COMCOVID trial — Johannes-Josef Tebbe, Stephan Budweiser, et al. · Advances in Therapy (2025) | TGRS Research Map | TGRS